Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_assertion type Assertion NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_head.
- NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_assertion description "[The number of different subpopulations of circulating endothelial cells (CECs), plasma levels of vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor 1 and 2 (sVEGFR-1,2) and placenta growth factor (PlGF) were determined in 30 patients with ET and 16 patients with PV.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_provenance.
- NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_assertion evidence source_evidence_literature NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_provenance.
- NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_assertion SIO_000772 20473593 NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_provenance.
- NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_assertion wasDerivedFrom befree-20140225 NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_provenance.
- NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_assertion wasGeneratedBy ECO_0000203 NP292715.RAn9jIWM-SFFgnchbU8M7uaU9zkK5EYJ_pU-OwB3ja3iQ130_provenance.